Get the content you want anytime you want.
REGISTER NOW | SIGN IN
VIDEO

What is The Benefit of Darunavir Versus Other HIV Medications?

JUL 26, 2017 | CONTAGION® EDITORIAL STAFF


Magda Opsomer, MD, Director, Clinical Leader, Infectious Diseases and Vaccines, Janssen Pharmaceutical Companies, Belgium, explains why darunavir may be more beneficial than other HIV medications.

Interview Transcript (slightly modified for readability)

“Darunavir is a boosted protease inhibitor and what is special about it is that it has a very high genetic barrier to the development of resistance. [This] is very important when it comes to treating patients, because as we know, resistance makes it more difficult to treat patients at the end.”
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.


FEATURED
We break down our top HIV news stories of 2017. Did you read them all?
x